BPC-157
Body Protection Compound-157
Also known as: Bepecin, PL 14736, Pentadecapeptide BPC 157
Last updated May 4, 2026
What is BPC-157?
If you’ve been dealing with an injury that won’t resolve and someone mentioned BPC-157, here’s what you need to know.
BPC-157 is a synthetic peptide of 15 amino acids derived from a protein in human gastric juice. It accelerates healing through angiogenesis, growth factor modulation and nitric oxide signaling. One of the most discussed peptides in biohacking and sports recovery due to extensive positive animal research. As of 2026, no large-scale human clinical trials have been completed.
What Does the Research Actually Show?
Multiple animal studies show accelerated healing. A 2010 Journal of Orthopaedic Research study showed faster tendon-to-bone healing in rats. A 2025 systematic review of 544 articles found only 1 clinical study meeting inclusion criteria.
Animal models show accelerated recovery from crush injuries with improved muscle fiber alignment.
Consistently positive animal data for ulcers, IBD and gut barrier damage. One Phase II human trial initiated but comprehensive results limited.
Without controlled human trials, we can’t rule out that practitioner-reported benefits are placebo, coincidental with other interventions or overstated. The mechanistic rationale is sound, but sound rationale isn’t proof.
How Is BPC-157 Administered?
| Route | Subcutaneous injection (most common); oral capsule for gut applications; nasal less common |
| Dosage range | 250–500 mcg per dose |
| Frequency | 1–2x daily |
| Protocol | Cycled use is the dominant pattern; cycle lengths and reassessment cadence vary by use case and provider |
| Access | Removed from Category 2 effective April 22, 2026; PCAC review scheduled July 23, 2026 |
For phase-by-phase response timing and signal-tracking guidance (joint and gut use), see our What to Expect on BPC-157 →
What Are the Side Effects and Risks?
- Nausea and digestive discomfort (mild, usually transient).
- Dizziness and headache (less common).
- Angiogenesis concern for cancer history — discuss with oncologist.
- Pregnancy is an absolute contraindication.
Who Should NOT Use BPC-157?
If you have an active malignancy or recent cancer history: BPC-157 promotes angiogenesis (the formation of new blood vessels). This is central to how it accelerates healing. It is also central to how tumors grow and metastasize. No human cancer case has been linked to BPC-157, but the biological mechanism is real, and zero studies have evaluated this risk in cancer patients. If you have an active cancer, are in remission or have a strong family history of cancer, this conversation belongs with your oncologist — not your peptide provider, not a Reddit thread.
If you are on anticoagulants (blood thinners): BPC-157 interacts with the nitric oxide system and has demonstrated effects on blood vessel formation and platelet function in animal models. If you are on warfarin, heparin, direct oral anticoagulants (DOACs like apixaban or rivaroxaban) or even daily aspirin therapy, the interaction profile is unstudied in humans. Your prescribing physician for the anticoagulant must be in the loop.
If you are on blood pressure medications: BPC-157’s nitric oxide pathway interactions could theoretically affect blood pressure regulation. If you’re on antihypertensives, particularly ACE inhibitors, ARBs or calcium channel blockers, your provider needs to monitor for unexpected changes in blood pressure during treatment.
If you are pregnant or breastfeeding: No safety data exists. This is not a situation where “probably fine” is an acceptable standard.
If you have a hormone-sensitive condition: This includes estrogen-receptor-positive breast cancer history, endometriosis, uterine fibroids or other conditions where angiogenesis or growth factor modulation could have downstream hormonal effects. The interaction is theoretical but biologically plausible.
If you are a competitive athlete in a tested league: BPC-157 is prohibited by WADA and most major US professional sports leagues. A positive test can end your season or career. “My provider prescribed it” is not a defense under anti-doping rules.
The lag in CRP response is worth understanding before drawing conclusions from a single result.
Before You Start: Get Baseline Labs
We recommend baseline lab work before starting any peptide protocol so you and your provider can track changes. Key markers include CBC, CMP, CRP (C-reactive protein) and inflammatory markers. If using for gut-related issues, consider a comprehensive stool panel.
Ask your provider about ordering these labs, or search for direct-to-consumer lab testing services in your area.
Order at-home labs from Everlywell →Lab recommendations are the same regardless of which service you use.
What You'll Need
If your provider prescribes an injectable protocol, you'll need basic supplies.
- Bacteriostatic Water (30ml)Link coming soon
- Insulin Syringes 29 gauge (100ct)Link coming soon
- Alcohol Prep Pads (200ct)Link coming soon
- Sharps ContainerLink coming soon
Supply links are affiliate links. We may earn a commission at no cost to you. We only link to commodity supplies, never to peptide products.
- 1Based on my injury, is BPC-157 appropriate or would you recommend a different approach first?
- 2Would you recommend BPC-157 alone or combined with TB-500?
- 3What dosage and injection site do you recommend for my specific condition?
- 4How will we monitor progress, and what does the timeline look like?
- 5Are there any contraindications given my health history?
- 6Which compounding pharmacy do you use, and is it 503A or 503B?
- 7What’s the total cost including consultation, labs and the peptide?
Is BPC-157 Legal in 2026?
Not FDA-approved. Removed from Category 2 effective April 22, 2026. PCAC review scheduled for July 23, 2026. Compounding cannot resume until after PCAC review and a final FDA determination adds BPC-157 to the 503A bulks list. Will be available via prescription through licensed compounding pharmacies — will NOT be available over the counter or FDA-approved.
How Do I Get BPC-157 Through a Legitimate Provider?
These providers meet our evaluation criteria: verified medical license, labs required before prescribing, and medications sourced from licensed U.S. pharmacies.
Peter MD
Hormone optimization, peptides, and longevity. Labs required before prescribing.
Not available in ID, AL. Lab work not available in NY, NJ, RI.
Book a ConsultationWe continuously evaluate providers. New additions will appear here as they’re verified.
These are affiliate links. We may earn a commission if you book through them. This never influences our evidence ratings or recommendations.